Vaccine Development
Course content
The primary aim of this course is to provide students with a comprehensive understanding of the entire vaccine development process, spanning from fundamental immunology to global implementation.
The course will be given by lecturers with expertise in both basic science and clinical practice, with strong representation of researchers and experts affiliated with Novo Nordisk Fondation Initiative for Vaccines and Immunity.
The curriculum covers a broad range of areas including:
- Early discovery
- Preclinical development
- Clinical development
- Clinical studies
- Manufacturing
- Regulatory aspects
- Commercialization and post-approval activities
The course introduces the fundamental concepts of drug discovery and development, as well as an array of preclinical platforms that model human diseases and support the clinical development of vaccines. Students will explore how these platforms facilitate the translation of basic immunological insights into therapeutic applications. In addition, the course introduces intellectual property rights, patent laws and regulatory frameworks relevant to vaccine discovery and development.
MSc in Immunology and Inflammation - elective course
After completing the course, students should have knowledge and competencies across scientific, clinical, regulatory and implementation domains. In particular they should be able to:
Knowledge:
- Explain the fundamentals of innate and adaptive immunity and describe how vaccines stimulate immune response
- Understand correlates of protection and immunological memory
- Understand and compare different vaccine platforms (e.g. live-attenuated, inactivated, subunit, viral vectors, mRNA)
- Explain antigen selection, adjuvant use, and formulation strategies
- Understand preclinical testing models and their role in translational research
- Outline the phases of clinical trials
- Describe good manufacturing practice (GMP) principles
- Explain scale-up, stability and quality assurance process
- Recognize challenges in vaccine production and distribution
- Understand regulatory pathways for vaccine approval
- Describe pharmacovigilance and postmarketing surveillance
- Explain the role of intellectual property, patent law, and global regulatory agencies
- Understand ethical considerations in vaccine trials and deployment
- Understand safety monitoring and risk-benefit analysis
- Appreciate global health initiatives and access challenges
Skills:
Students should leave the course with an integrated understanding of how vaccines move from basic immunological discovery to global public health implementation, and be equipped to critically engage with scientific, clinical and policy discussions in the field.
Students should be able to get engaged thoroughly and competently in research, clinical development, regulatory affairs and public health initiatives related to vaccine development. After completing the course students should have developed the following skills:
- Critical analysis skills – ability to evaluate scientific literature, interpret immunological and clinical data, assess vaccine efficacy and safety
- Translation thinking - ability to connect basic immunological mechanisms to vaccine design and clinical application
- Research literacy – understand preclinical models, clinical trials design, and data interpretation
- Regulatory awareness – ability to navigate through regulatory networks, ethical considerations, and intellectual property issues related to vaccine development
- Risk-benefit assessment – ability to weigh safety, effectiveness, and public health implications
- Scientific communication – ability to clearly communicate vaccine-related concepts to scientific and non-specialist audiences.
- Problem solving skills – capacity to analyze real-world challenges in vaccine development, approval, and implementation
Competences:
- The students should be able to come up with a conceivable plan for a specific vaccine development project.
- The students will be equipped with comprehensive understanding of vaccine science including principles of immunology, vaccine development, manufacturing, safety, and efficacy in order to prepare them to contribute effectively to immunization programs, research, public health policy, and disease prevention.
- The students will be capable to participate in cross disciplinary teams, with researchers working both in academia and industry, and critically discuss vaccine development projects.
Broad range of teaching methods will be used; lectures and seminars will be given by experts in different areas. Students will work individually and in small groups on different assignments. Relevant publications will be discussed during journal clubs.
Original articles and reviews.
Comprehensive knowledge (a minimum of 7,5 ECTS) in basic immunology and immune pathology is highly recommended.
Self Service at KUnet
Open for credit transfer students and other external students. Apply here:
Credit transfer students:
https://healthsciences.ku.dk/education/for-students/credit-transfer-students/
Other external students:
http://healthsciences.ku.dk/education/exchange_guest_students/guest-students/
- ECTS
- 7,5 ECTS
- Type of assessment
-
On-site written exam, 3 hours under invigilation
- Examination prerequisites
-
Attendance + active participation in journal clubs and presentations + approved projects assignments (written report)
- Aid
- No aids allowed
- Marking scale
- 7-point grading scale
- Censorship form
- No external censorship
- Exam period
-
See exam plan.
- Re-exam
-
Oral exam, no aid, 30 minutes preparation, 30 minutes exam.
Criteria for exam assessment
To achieve the maximum grade of 12, the student shall:
- Actively participate in lectures, presentations, journal clubs
- Be able to critically discuss scientific publications
- Name emerging and neglected viral and bacterial diseases
- Describe few human pathogenic bacteria
- Describe few human pathogenic viruses
- Understand traditional vaccine platforms: inactivated, live-attenuated, subunit vaccines
- Understand modern vaccine technologies: mRNA, DNA, viral vectors
- Understand adjuvants and delivery systems: lipid nanoparticles, polymers, emulsions
- Explain the fundamentals of innate and adaptive immunity and describe how vaccines stimulate immune response
- Understand correlates of protection and immunological memory
- Understand preclinical testing models and their role in translational research
- Discuss potential adverse effects induced by vaccines
- Describe key drug development phases (drug discovery, preclinical testing, clinical trials, manufacturing and regulatory affairs)
- Explain principles of pandemic preparedness
- Understand the role of global immunization strategies and health organizations: GAVI, COVAX, IVI, CEPI, WHO
- Outline the phases of clinical trials
- Describe good manufacturing practice (GMP) principles
- Explain scale-up, stability and quality assurance process
- Recognize challenges in vaccine production and distribution
- Explain regulatory pathways for vaccine approval
- Describe pharmacovigilance and postmarketing surveillance
- Explain the role of intellectual property, patent law, and global regulatory agencies
- Understand safety monitoring and risk-benefit analysis
- Describe innovative approaches (for example: mucosal immunity, personalized vaccines)
- Category
- Hours
- Lectures
- 28
- Class Instruction
- 20
- Preparation
- 155,25
- Exam
- 3
- English
- 206,25
Kursusinformation
- Language
- English
- Course number
- SIIK26001U
- ECTS
- 7,5 ECTS
- Programme level
- Full Degree Master
- Duration
-
1 block
- Placement
- Block 4
- Capacity
- 30
- Studyboard
- Study Board for Human Biology, Immunology and Neuroscience
Contracting department
- Department of Immunology and Microbiology
Contracting faculty
- Faculty of Health and Medical Sciences
Course Coordinator
- Joanna Sylwia Rejman (13-73786a77776a377b6e73766a77497c7e776d37747e376d74)
Teacher
The course will be given by lecturers with expertise in both basic science and clinical practice, with strong representation of researchers and experts affiliated with Novo Nordisk Foundation Initiative for Vaccines and Immunity.
Er du BA- eller KA-studerende?
Kursusinformation for indskrevne studerende